Submitted by Anonymous (not verified) on 13 August 2026 - 12:49
Human medicines European public assessment report (EPAR): Exdensur, depemokimab, Date of authorisation: 12/02/2026, Revision: 2, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Exdensur, depemokimab, Date of authorisation: 12/02/2026, Revision: 2, Status: Authorised